Patients with #cancer who are #sarcopenic likely have significant #eGFR overestimation. Here we found that sarcopenia is associated with widely discrepant eGFR-creatinine and eGFR-cystatin C in a large cohort of patients who underwent body comp analysis.

doi.org/10.1002/jcsm.1…

Multiple factors can impact serum creatinine, particularly in the acute setting. #KidneyCon

Total solar eclipse in Cleveland. Happy to have a short down time in between cases to capture this! Cleveland Clinic

New study finds that a simple risk score could predict the risk of severe cisplatin associated acute kidney injury, the occurrence of which is strongly associated with death
@ShrutiGKidney
bmj.com/content/384/bm…

A risk score for cisplatin-induced AKI. Next let's test prevention in high risk patients!

bmj.com/content/384/bm…

MGH Onconephrology Shruti Gupta David Leaf

AKI and CKD risks are increased in cancer survivors receiving BRAF for melanoma.
academic.oup.com/ndt/advance-ar…

MGH Onconephrology Kavita Mistry

Love you Roby Bhattacharyya is also @roby-b.bsky.social

Patients with ESRD with COVID-19 hit the emergency room early in symptom onset- opportunity to treat them early with antivirals. medrxiv.org/cgi/content/sh…

In NEJM Group's final report on #KidneyWk , our clinician-guides, meg sise and Opeyemi Olabisi, share key takeaways from the nephrology meeting and how these findings might change their practice. jwat.ch/40r4XWx

Very excited for #KidneyWk

cdn.jwplayer.com/players/9rEWA5…

Opeyemi Olabisi NEJM Journal Watch

🎊Congratulations Paul E. Hanna, MD MSc and team!!

Excited to share our VSPI related HTN/ proteinuria research ASON Live MCW Nephrology Shruti Gupta meg sise MGH Onconephrology

Full house at the American Society of Onconephrology symposium. Excellent turn out !! Sreedhar Mandayam Helbert Rondon, MD, MS, FACP, FASN, FNKF Kenar Jhaveri BT Workeneh Arash Rashidi

Pyelonephritis presents subclinically in patients with ileal neobladder, and #nephrologists need to keep a high index of suspicion w fatigue and worsening eGFR. #onconephrology Paul E. Hanna, MD MSc Qiyu Wang

sciencedirect.com/science/articl…

How cool is this? Listen to the first ASON podcast where Shruti Gupta and meg sise discuss their careers as physician scientists!!!

Raad Chowdhury, MD, FASN Arash Rashidi BT Workeneh

youtu.be/UNpQZAYucnQ

New in #npjBCancer , CDK4/6 inhibitors improve survival in metastatic breast cancer, but their impact on kidneys is unknown. Paul E. Hanna, MD MSc et al show that mild early kidney function decline is common but severe damage & long-term adverse outcomes are rare go.nature.com/3YYm0i5

Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease sciencedirect.com/science/articl… purva sharma Mass General Kidneys AKDH National Kidney Foundation

Our most recent review of #hepatitisB and #hepatitisC in patients with kidney disease #CKD . purva sharma in AKDH
sciencedirect.com/science/articl…

Reassuring findings: early eGFR decline w Cdk4/6 inhibitors not associated w severe AKI or long term kidney function decline. Early eGFR decline appears to be largest/most common w abemaciclib. We recommend cystatin C!nature.com/articles/s4152…

#TeamSise found that severe AKI and the composite adverse kidney outcome were uncommon in patients receiving CDK4/6 inhibitors! Strong work Paul E. Hanna, MD MSc meg sise